| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0003-4975(01)02995-2 |
| P698 | PubMed publication ID | 11603428 |
| P50 | author | Mark G Kris | Q37621431 |
| Valerie W Rusch | Q51775643 | ||
| P2093 | author name string | J Martin | |
| E S Venkatraman | |||
| T L Weigel | |||
| A Abolhoda | |||
| R J Ginsberg | |||
| M S Bains | |||
| R J Downey | |||
| R J Korst | |||
| P2860 | cites work | Revisions in the International System for Staging Lung Cancer | Q28241070 |
| Use of pleura, azygos vein, pericardium, and muscle flaps in tracheobronchial surgery | Q40484088 | ||
| Optimizing selection of patients for major lung resection | Q43969421 | ||
| Induction chemotherapy before surgery for early-stage lung cancer: A novel approach | Q59566197 | ||
| Elective pneumonectomy: Factors associated with morbidity and operative mortality | Q68164192 | ||
| Determinants of perioperative morbidity and mortality after pneumonectomy | Q69690748 | ||
| Complications of surgery in the treatment of carcinoma of the lung | Q70368808 | ||
| Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients | Q70460340 | ||
| Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias | Q71054143 | ||
| Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 | Q71961890 | ||
| Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer | Q72876250 | ||
| Postoperative complications after combined neoadjuvant treatment of lung cancer | Q72963189 | ||
| Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica | Q73283383 | ||
| Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancer | Q73892663 | ||
| Safe pulmonary resection after chemotherapy and high-dose thoracic radiation | Q78213664 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonectomy | Q46565 |
| lung cancer | Q47912 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1149-1154 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
| P1476 | title | Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy | |
| P478 | volume | 72 |
| Q36752521 | A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer |
| Q38115159 | Acute respiratory distress syndrome after pulmonary resection |
| Q46788430 | Analysis of prognostic factors for surgery after neo-adjuvant therapy for stage III non-small cell lung cancer |
| Q47131619 | Bronchoscopic management of prolonged air leak |
| Q30897591 | Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis |
| Q89822861 | Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer |
| Q33184411 | Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity |
| Q35039285 | Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer? |
| Q53745985 | Extended surgery for T4 lung cancer: a 30 years' experience. |
| Q37245399 | Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities |
| Q36609576 | How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer |
| Q51727257 | Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. |
| Q79278145 | Induction Therapy for Early-Stage Lung Cancer? The Rationale Behind the Question |
| Q35543230 | Induction chemotherapy followed by radical local therapy for locally advanced non‐small cell lung cancer |
| Q79912267 | Induction concurrent chemoradiation therapy for invading apical non-small cell lung cancer |
| Q36194277 | Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis |
| Q99583010 | Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team |
| Q35008714 | Lung cancer surgery: acceptable morbidity and mortality, expected results and quality control |
| Q83266522 | Lung sparing surgery by means of extended broncho-angioplastic (sleeve) lobectomies |
| Q36883654 | Management of locally advanced non small cell lung cancer from a surgical perspective |
| Q33186857 | Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial |
| Q51720535 | Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function. |
| Q34445402 | Morbidity and mortality after pneumonectomy in smokers with NSCLC |
| Q45928445 | Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. |
| Q34821980 | Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer |
| Q43937565 | Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective |
| Q37089137 | Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience |
| Q36479805 | Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy. |
| Q44052340 | Pneumonectomy for non-small cell lung cancer |
| Q28190992 | Pneumonectomy: historical perspective and prospective insight |
| Q53593114 | Prevalence and mortality of acute lung injury and ARDS after lung resection. |
| Q97538139 | Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes |
| Q27331599 | ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer |
| Q44730217 | Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? |
| Q46330671 | Results of surgical treatment after neoadjuvant chemotherapy for stage III non-small cell lung cancer. |
| Q44630217 | Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer |
| Q42354996 | Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer |
| Q79357059 | Safety of bronchoplastic resection after induction therapy for lung cancer |
| Q35894646 | Sleeve resection after induction therapy |
| Q34571781 | Standard versus extended pneumonectomy for lung cancer: what really matters? |
| Q33813436 | Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial |
| Q54099068 | Surgical Treatment of Lung Cancer. |
| Q35845171 | Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins |
| Q84582193 | Surgical treatment of stage III non-small cell lung cancer |
| Q64235268 | Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis |
| Q53288192 | Survival of patients with clinical stage IIIA non–small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors |
| Q43055346 | The long-term outcomes of induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer |
| Q73311188 | Tumor stage and early mortality for surgical resections in lung cancer |
| Q37303365 | UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome |
| Q74451557 | What's new in general thoracic surgery |
| Q40494915 | Which is the Role of Pneumonectomy in the Era of Parenchymal-Sparing Procedures? Early/Long-Term Survival and Functional Results of a Single-Center Experience |
| Q81205224 | [Surgical treatment of non-small cell lung cancer] |
| Q53271315 | [The evaluation of pneumonectomy and bronchoplasty lobectomy in the treatment of non-small cell lung cancer: a report of 64 cases]. |
Search more.